Objective. To determine the incidence of adverse drug events (ADEs) and assess their severity and preventability.
Introduction
Adverse drug events (ADEs) and medication errors are worldwide concern for healthcare policy-makers, healthcare professionals and the public. It is estimated that in the USA each year, medication errors harm at least 1.5 million people, resulting in 106 000 deaths, and treating injuries caused by these errors costs at least 3.5 billion dollars [1, 2] . Studies conducted in the USA and other countries provide an estimate of the incidence of ADEs in the hospital setting. In a USA study in two academic hospitals, the incidence of ADEs for hospitalized patients was estimated to be 6.5 per 100 admissions [3] . A recent study in six community hospitals found an even higher rate of ADEs (15 per 100 admissions) [4] . In Japan, a study in three hospitals reported the incidence of ADEs in hospitalized patients was 29 per 100 admissions [5] . The incidence of ADEs in the Australian study was estimated to be 10% [6] , while the incidence in a study conducted in New Zealand was found to be 15% [7] . In Morocco, a multicentre study investigated the incidence of ADEs and medication errors in medical and surgical intensive care units. The study reported ADEs incidence of 11.5 per 100 admissions and medication errors incidence of 7.5 per 100 admissions [8] .
Large hospitals in Saudi Arabia are like academic centers in many other regions, although cultural issues are important and may affect safety in a variety of ways. For example, some types of interactions between men and women are limited, many providers come from outside Saudi Arabia, and language issues and hierarchies are important. In addition, Saudi hospitals vary widely in their level of development. Several studies conducted in Saudi Arabia, have investigated issues such as prescribing errors [9] [10] [11] , hospital admissions due to adverse drug reactions [12] and patient safety culture [13] . One study found that discharge counseling by pharmacist decreases the incidence of ADEs [14] . In Saudi Arabia and the Middle East at large, however, studies of the incidence and outcomes of medication errors and ADEs occurring in hospitals are scarce. We believed it would help to assess the epidemiology of medication safety in a hospital in order to compare the current status of patient safety problems in Saudi Arabia with studies from the developed world. Also, these studies will help develop future interventions that aim to reduce ADEs. Therefore, the objectives of the current study were to determine the incidence of in-hospital ADEs, potential ADEs and medication errors in an academic tertiary hospital in Saudi Arabia and to classify their severity and preventability.
Methods

Study design and patient population
This prospective cohort study was conducted at a 900-bed tertiary academic hospital in Riyadh, Saudi Arabia. Similar to university-affiliated hospitals in developed countries, medical care in this hospital is supervised by attending physicians and delivered by medical residents, interns and students. Medications are ordered on paper only by physicians. After they are transcribed, medication orders are then sent to the inpatient pharmacy where pharmacists review orders and enter them into the computer system, and these data are used to print the prescription container labels. Medications are dispensed by pharmacists using a unit dose system. Subsequently, nurses administer patients' medications and record them manually in paper medication administration records.
The hospital includes four intensive care units, eight medical units and five surgical units. A simple random sampling technique was used to select five units as follows: two intensive care units (one medical and one surgical), two medical units and one surgical unit. We included all patients older than 12 years of age admitted to these units from May to August 2010. We limited the study to patients older than 12 years since it is the minimum age for a patient to be admitted to our adult wards. Patients staying <24 h were excluded from the study to allow sufficient time for patient follow-up. The study was approved by the hospital research and ethics committee.
Definitions
An ADE is an injury caused by a medication, which include both adverse drug reactions (an effect which is noxious and unintended, and which occurs at doses used in man for prophylaxis, diagnosis or therapy [15] ) as well as harmful effects arising from errors at any medication use stage including ordering, transcribing, dispensing, administering or monitoring of a drug [16] . For this study, examples of harm caused by medications include symptomatic physiological changes, organ damage and toxicity, allergies, altered mental status and abnormal laboratory results if they indicated organ damage such as renal insufficiency or hepatic toxicity. ADEs caused by adverse drug reactions (e.g. fever after vaccination) are not associated with errors, and were considered nonpreventable, while those ADEs caused by medication errors are considered preventable [17] . Categories E, F, G, H and I, medication errors led to harm or death, in the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) were defined as harm from medications [18] . A potential ADE is an error that carries the risk of causing injury related to the use of a medication but harm did not occur, either because the error was intercepted before reaching the patient or because the patient fortuitously did not suffer harm despite receiving the medication [17] . Some medication errors may result in harm to patients, but some may not. Examples of medication errors include illegibility, errors in medication dose (orders without dosage units or orders without strength), errors in route of administration, errors in directions for use and use of inappropriate abbreviations. Also considered medication errors were omissions of clinically indicated medications, orders without a date or an incorrect date and orders without a weight when weight-based dosing was necessary. Categories B, C and D, medication errors with no harm, in the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) were defined as medication errors [18] .
Data collection and classification of incidents
Three study pharmacists received 3 days of training by the study investigators before starting data collection, and were provided with a study manual. A step-by-step method of data collection, and examples of ADEs, potential ADEs and medication errors were explained to the study pharmacists. An in-service awareness was conducted monthly for nurses in each study unit to increase the awareness about voluntary reporting of ADEs and medication errors. Nurses and other healthcare professionals were encouraged to report medication errors and ADEs to increase the number of reports through voluntary anonymous reports using a box placed in each unit, pharmacy communication forms and incident reports. Therefore, incidents were identified through a combination of medical record review by study pharmacists and voluntary reports from other healthcare professionals.
Each day, the study pharmacist identified new admissions by reviewing the patient admission book in each study unit. The study pharmacists conducted daily medical record reviews for all patients in the participating units and completed data forms that included extensive descriptions of the case findings. Trigger tool was used to guide chart review further. The tool included a list of drugs and laboratory tests as a clue that ADEs may have occurred.
Data elements were gathered by the study pharmacists for each incident included age and gender of the patient, admitting unit and diagnosis, time and date of any incidents, name, dose, and category of the drug involved, source of the incident report and a narrative description of the incident. The incident description was used to determine the nature and origin of the incident, brief patient history, medication use stage at which the incident occurred, medication involved and how the error was resolved. Comorbidity was assessed using the Charlson's comorbidity index, which has been established to be reliable and valid [19, 20] . The case log also included the length of the hospital stay, which was used to calculate the incidence of ADEs per patient-days and per admissions. In addition, the number of routine medications and as needed medications prescribed for each patient upon admission was also collected.
Two reviewers, a physician and a consultant clinical pharmacist who were not involved in the data collection, were provided with a study manual that contains study terminology definitions and incident and severity classifications, using a methodology developed by Brigham and Women's Hospital, the Center for Excellence for Patient Safety Research and Practice [3] . This study manual served as a guide for the reviewers to include or exclude incidents as ADEs, potential ADEs or ME and further classify the severity and preventability.
Both reviewers independently evaluated the possible ADEs, classified confirmed incidents, and judged their severity and preventability. They first determined the likelihood that the event was caused by a medication. The reviewers then classified incidents as medication errors, potential ADEs or ADEs. The stages at which the medication errors occur (ordering, transcribing, dispensing and administering) were also classified. Next, incidents were classified according to severity as fatal, life threatening, serious or significant [17] . Life-threatening ADEs were those that caused symptoms or changes that, if not treated, would put the patient at risk of death, or elevated or depressed laboratory values that could put critical physiologic functions at risk of failure. Serious ADEs were events that caused persistent alteration of life function, or elevated or depressed life values that required medical intervention, especially where suggestive of organ system dysfunction. An ADE was considered significant if the event caused symptoms that, while harmful to the patient, posed little or no threat to the patient's life. Then, incidents were classified according to preventability using the previously mentioned definition to preventable ADEs (if classified by reviewers as definitely preventable or probably preventable) and as non-preventable ADEs (if classified by reviewers as probably not preventable or definitely not preventable). When potential ADEs were judged to have been occurred, they were further classified as intercepted or non-intercepted potential ADEs. Intercepted potential ADEs were those that had the potential to cause injury but did not reach the patient, because they were intercepted by someone during the medication use process. An example would be an overdose of a medication prescribed for a patient and intercepted by the pharmacist before it reaches the patient. Non-intercepted potential ADEs were those with the potential to cause harm but failed to do so after the medication reached the patient. An example would be when a febrile patient with elevated liver function tests (LFTs) who was ordered to receive acetaminophen 650 mg but instead was administered acetaminophen 1000 mg, but had no increase in LFTs or associated symptoms. Medication errors with low potential to cause harm which were not associated with preventable ADEs or potential ADEs were classified as medication errors.
Study outcomes and statistical analysis
The primary outcomes of this study were the frequency of ADEs (defined as an injury resulting from a medication), potential ADEs (defined as incidents with the risk for injury from a medication but none occurred) and medication errors. The secondary outcomes were the severity of these events, their preventability and the associated risk factors.
Continuous variables are presented as mean ± standard deviation (SD) and categorical variables as number and percentages. Incidents per 1000 patient-days, crude rate per 100 admissions and their 95% confidence intervals were calculated. Inter-rater reliability was assessed using the kappa statistic for assessment of the presence of an ADE and its preventability and severity. The kappa value for the presence of ADEs was 0.86 and for the presence of potential ADEs it was 0.75. The kappa value for preventability of ADEs was 0.82 (definitely or probably preventable vs. definitely or probably not preventable). For the severity of ADEs the kappa score was 0.79 (life threatening vs. serious or significant), 0.71 (significant vs. serious or life threatening) and 0.67 (serious vs. significant or life threatening). To evaluate the univariate association of risk factors with ADEs, we used logistic regression. Statistical analyses were conducted using the Statistical Package for Social Science (SPSS) software (SPSS, Inc., Chicago, IL), version 16.0.
Results
During the study period, there were 977 admissions with 9585 patient-days in the 5 study units (Table 1) . Among the included patients, 65% were female and the mean age was 48.9 years. The mean length of a hospital stay was 10 days and the mean Fig. 1 ). Of the 23 incidents identified by voluntary reporting, 6 were from medical and surgical ICUs, 12 from medical units and 5 from surgical units. Reviewers accepted 281 incidents in 207 patients and excluded 80 incidents in 54 patients. Of these accepted incidents, 83 were ADEs in 68 patients, out of which 25 (30%) were judged definitely or probably preventable. Two hundred and twenty-three incidents were classified as medication errors, of which 132 (59%) had the potential to cause harm. Examples of these ADEs are listed in Appendix I.
Adverse drug events
The incidence of ADEs was 8.7 (95% CI 6.9-10.6) per 1000 patient-days or 8.5 (95% CI 6.8-10.4) per 100 admissions ( Table 2 ). Incidences of preventable and non-preventable ADEs were 2.6 (95% CI 1.6-3.7) and 6 (95% CI 4.5-7.6) per 100 admissions, respectively. The incidence of ADEs was higher in ICUs (21.1; 95% CI 15.1-28.8 per 100 admissions). Severity of ADEs was 59% significant, 35% serious and 6% life threatening; no fatal cases were noted. Preventable ADEs occurred most commonly in the ordering stage 24 (96%) ( Table 3) .
Drug classes and ADEs
The frequency of ADEs by drug class is shown in Table 4 . Anticoagulants accounted for one-third of all ADEs and thus represented the medication class most frequently associated with ADEs. Antibiotics and antihypertensives accounted for 21 and 16% of ADEs, respectively. Preventable ADEs were more common with antibiotics, antihypertensives, diuretics and non-steroidal anti-inflammatory drugs, whereas anticoagulants were the most frequent non-preventable ADE. Several factors were associated with ADEs (Table 5) . Patients admitted to the ICU odds ratio (95% CI) 2.250 (1.176-4.306) were at higher risk of ADEs than those admitted to other units. Other factors significantly associated with ADEs were older age, Charlson's comorbidity score and numbers of medications (Table 5) .
Medication errors and potential ADEs
We identified 223 medication errors among 172 patients, an incidence of 23 (Table 2) . Sixty-six incidents were errors but were not considered ADEs because there was low risk of harm to the patient. Forty-eight (36%) of the potential ADEs were intercepted before the drug was administered to the patient, whereas 84 (64%) were non-intercepted potential ADEs. The incidence of intercepted and non-intercepted potential ADEs were 4.9 (95% CI 3.7-6.5) and 8.6 (95% CI 6.9-10.5) per 100 admissions, respectively. Among potential ADEs, life-threatening events accounted for 2%, serious ADEs accounted for 44% and significant ADEs accounted for 55%. There were no fatal ADEs. Intercepted potential ADEs most commonly occurred in the ordering stage 37 (77%), followed by the dispensing stage 20 (24%) ( Table 3) .
Discussion
Few data are available on the frequency of in-hospital ADEs in developing or transitional countries, and to our knowledge this is the first study estimating their incidence in Saudi Arabia. Overall, the patterns of harm were fairly similar to those from developed countries. In particular, ICU patients had a higher rate of harm than other patients with a rate of 21%; this is consistent with the results from previous studies [3, 5] . Among all ADEs, 6% were rated as life threatening, 35% as serious and 59% as significant. The common drug classes involved were anticoagulants, antibiotics and antihypertensives. The median number of medications on admission in our study was 2 (range 0-14) was lower than that reported by a similar study from Japan (median was 4, range was 0-17) [5] . This might explain the lower incidence of ADEs in our study compared with the recent study in Japan (8.5 vs. 29 per 100 admissions) [5] .
Our results are comparable to other studies conducted in different parts of the world [3, [5] [6] [7] [8] (Table 6) . Using similar methods, the incidence of in-hospital ADEs in this academic Figure 1 Incidents classification flow chart. hospital in Saudi Arabia was comparable to the incidence reported in the USA but lower than those reported in Japan [3, 5] . The ADE Prevention Study in the USA included 4031 patients admitted to 11 medical and surgical units in 2 tertiary care hospitals. Over 6 months, 247 ADEs and 194 potential ADEs were identified, and the rate of ADEs was 6.5 per 100 admissions [3] . However, a study in 2010 found that the rate of ADEs in 6 community hospitals was 15 per 100 admissions [4] . In Japan, a study in 3 hospitals reported that the incidence of ADEs was 29 per 100 admissions (17 per 1000 patient-days) [5] . Our study has several limitations. It was performed in a single academic hospital, which limits the generalizability of the study results. However, this hospital provides free services to patients from the general population of the country. We used methods to detect ADEs that relied mainly on information recorded in the medical records and heightened awareness by nurses. Thus, we likely missed some incidents that were not documented in the medical record or otherwise reported; however, creating a greater awareness among nurses may have increased the yield of detection.
The current study has important practical and research implications. In the last few years, efforts to prevent medication errors have increased in developed and developing countries. However, more resources are needed for training, research and implementation of the prevention practices. This study serves as an important baseline in Saudi Arabia for future medication safety interventions and can help hospitals justify activities promoting safety. To improve the quality of care, administrators and healthcare professionals need to treat the prevention of medication errors as a priority. Solutions to prevent medication errors in hospitals include the use of information technology and automation, establishing medication safety programs, and perhaps involving pharmacists in the medication monitoring process [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] . However, these solutions need to be fully evaluated in developing countries. Therefore, future studies should be conducted to identify the causes of these errors and suggest and evaluate solutions to prevent them. In addition, promoting a culture of safety is a key element for stimulating the reporting of errors within healthcare organizations.
The incidence of ADEs in a teaching hospital in Saudi Arabia was 8.5 per 100 admissions: lower than in Japan, but higher than in tertiary hospital in the USA. Preventable ADEs most commonly occurred in the ordering stage; therefore, interventions that aim to reduce ADEs should target the ordering stage.
